Complete revascularization proves effective for older STEMI patients in first 4 years

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Prevounce Health Closes $7M to Scale Remote Care Management Solutions

What You Should Know: – Prevounce Health, a provider of remote care management software, devices, and services closes $2.5M in new Series A funding led

October 14, 2023

Advances in ALL at ASH Meeting Include New Blinatumomab Data and More

In the phase III ECOG-ACRIN E1910 study presented at the American Society of Hematology (ASH) annual meeting, consolidation chemotherapy with blinatumomab (Blincyto) improved overall survival

December 19, 2024

Second Phase 3 Study of MDMA-assisted Therapy Reports Positive Results, Paving Way for New Drug Application | Psychedelic Invest

The Multidisciplinary Association for Psychedelic Studies (MAPS) and its Public Benefit Corp. arm, MAPS PBC, today published its second Phase 3 study (MAPP2) of MDMA-assisted therapy (MDMA-AT)

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.